Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study.

Ran, Shu; Pan, Lixin; Liu, Baolin

Ran, Shu; Pan, Lixin; Liu, Baolin.

Ran S; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China shuran@usst.edu.cn.
Pan L; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Liu B; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.

Lupus Sci Med ; 9(1)2022 08.

Article in English | MEDLINE | ID: covidwho-2001887

Subject(s)

COVID-19; Lupus Erythematosus, Systemic; Humans; Lupus Erythematosus, Systemic/complications; Lupus Erythematosus, Systemic/epidemiology; Risk Factors

Keywords

COVID-19; epidemiology; lupus erythematosus, systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lupus Erythematosus, Systemic Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Lupus-2022-000786

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google